Similarly, in chronic lymphocytic leukemia (CLL), CD38, a marker of poor prognosis, increased intracellular Ca2+ concentrations by converting NAD+ to ADPR and cADPR. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.